6550--Amarillo Chemistry CPRR Bridge
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
No listed company matched (Materiality N/A)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25725AP2464 in this department, oldest first.
- Jun 24, 2025 · this noticeAward NoticeBECKMAN COULTER, INC · $1.3M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Amarillo VA Chemistry CPRR One Year Bridge Please see Award Notice and Limited Sources Justification.
Who won similar work
7 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6550 and NAICS 334516.
Single-winner award sizes (7): middle half $137K to $1.7M, median $426K; range $95K to $3.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| TOSOH BIOSCIENCE, INC. | 1 | $3.0M | Nov 10, 2025 |
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 1 | $2.5M | Nov 19, 2025 |
| BRANCH MEDICAL LLC · $GMED · $1.6B | 1 | $900K | Oct 28, 2025 |
| BECKMAN COULTER, INC | 1 | $426K | Nov 25, 2024 |
| DIAGNOSTICA STAGO INC | 1 | $142K | Jul 14, 2026 |
| ROCHE DIAGNOSTICS CORPORATION | 1 | $132K | May 15, 2026 |
| DIASORIN INC | 1 | $95K | Nov 4, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $GMED reported $1.6B revenue in FY2025. The median single-winner award in these 7 past awards, $426K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Jul 14, 2026DIAGNOSTICA STAGO INC$142K6550--Coagulation Cost-Per-Reportable-Result (CPRR)No listed company matched (Materiality N/A)
- May 15, 2026ROCHE DIAGNOSTICS CORPORATION$132K6550--Benchmark Ultra PlusNo listed company matched (Materiality N/A)
- Nov 19, 2025POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$2.5M6550--New - VISN 17 FIT ConsolidationNo listed company matched (Materiality N/A)
- Nov 10, 2025TOSOH BIOSCIENCE, INC.$3.0M6550--VISN 17 A1c CPRR BPANo listed company matched (Materiality N/A)
- Nov 4, 2025DIASORIN INC$95K6550--NTX Infectious Disease Contract - Base BPA OrderNo listed company matched (Materiality N/A)
- Oct 28, 2025BRANCH MEDICAL LLC$900K6550--Central Texas VA Chemistry QC Products IDIQMateriality: 0.06% of $GMED revenue (Low) SEC
- Nov 25, 2024BECKMAN COULTER, INC$426K6550--Antimicrobial Susceptibility Instrument CPRR BPANo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.